ATACAND PLUS

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, Ireland, Israel, Malta, Mexico, Nigeria, Netherlands, Singapore, Turkey, South Africa

Active ingredients

The drug ATACAND PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1 Candesartan UNII R85M2X0D68 - CANDESARTAN CILEXETIL

Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration. Read about Candesartan

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA06	Candesartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8504N, 9314F, 9315G
Country: CA	Health Products and Food Branch	Identifier(s): 02244021, 02332922, 02332957
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00597647, 00986107, 00986113, 00986136, 01581660, 01581737, 04152853, 04152876, 04649022, 05107984, 05108096, 05108216, 05108334, 05108452, 05356546, 06102397, 06102428, 07548072, 07548184, 07573992, 07628948, 07628954, 09042891, 12652268, 13922787, 13922793, 17164912
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H6490913, H6600913
Country: EE	Ravimiamet	Identifier(s): 1132568, 1132579, 1132580, 1132591, 1132603, 1132614, 1132625, 1132636, 1132647, 1132658, 1393679, 1393680, 1393691, 1393703, 1393714, 1393725, 1393736, 1393747, 1393758, 1393769, 1393770, 1393781, 1393792, 1393804, 1393815, 1393826, 1393837, 1393848, 1393859, 1393860, 1594414
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63209, 71062, 71068
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 029706, 029729, 057042
Country: IE	Health Products Regulatory Authority	Identifier(s): 13818, 14013, 15405, 15437
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6445
Country: MT	Medicines Authority	Identifier(s): AA908/09702
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 401M2001
Country: NG	Registered Drug Product Database	Identifier(s): A4-9456, B4-0338
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 56170
Country: SG	Health Sciences Authority	Identifier(s): 11383P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786010055
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/7.1.3/0923